After vessel occlusion, the gradual occurrence of astrocyte damage and BBB disintegration (usually not before 6 to 12 h after stroke onset) leads to a delayed release of GFAP into the plasma, not reaching peak concentrations before 48–96 h after symptoms onset [18,79,80,81,82]. This evidence concerns the gene GFAP and stroke disorder.